$STXS News Tuesday’s biggest gaining and declining

New Post Public Reply Private Reply Replies (0) Message Board

Jan 5, 2015 at 12:48 PM

$STXS News

Tuesday’s biggest gaining and declining stocks 4:20 p.m. Aug. 9, 2011 - Kate Gibson
Tuesday's biggest gaining and declining stocks 3:50 p.m. July 13, 2010 - MarketWatch
Stereotaxis to sell 1.92 mln shares for $10.50 each 10:40 a.m. March 16, 2007 - Gabriel Madway
Stereotaxis to sell 1.92M shares for $10.50 each 10:22 a.m. March 16, 2007 - Gabriel Madway
Updates, advisories and surprises 5:01 p.m. Nov. 10, 2006 - MarketWatch
Friday's biggest stock gainers and decliners 4:42 p.m. Nov. 10, 2006 - MarketWatch
Stereotaxis shares fall on third-quarter results 2:51 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis still sees 2006 rev of $26M-$30M 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis Q3 rev $7.64M vs $1.69M 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis Q3 net loss 34c vs 44c 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis shares fall on Q3 results 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis avg daily volume 340K shares 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis volume 910K shares 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Stereotaxis shares down 13% at at $10.50 2:34 p.m. Nov. 10, 2006 - Gabriel Madway
Thursday's biggest stock gainers and decliners 4:54 p.m. Aug. 10, 2006 - Michael Baron
Stereoaxis upped to buy at A.G. Edwards 9:23 a.m. Aug. 10, 2006 - Tomi Kilgore
Medicare reimbursement plan gives boost to device makers 2:46 p.m. Aug. 2, 2006 - Russ Britt
Stereotaxis: Technology used in remote cases at Cardostim 2:38 p.m. June 16, 2006 - Gabriel Madway
Stereotaxis says its technology was used in remote cases 2:38 p.m. June 16, 2006 - Gabriel Madway
Stereotaxis shares up 8.7% at $10 2:38 p.m. June 16, 2006 - Gabriel Madway

Stereotaxis (STXS) Stock Soars Today After FDA Clears Vdrive for Market Entry 42 min ago - TheStreet.com
Insider Trading Alert - CODE, COV And STXS Traded By Insiders 11:37 a.m. Dec. 9, 2014 - TheStreet.com
10-Q: STEREOTAXIS, INC. 3:41 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Stereotaxis' CEO William Mills on Q3 2014 Results - Earnings Call Transcript 6:10 p.m. Nov. 5, 2014 - Seeking Alpha
Stereotaxis (STXS) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 5, 2014 - Seeking Alpha
Stereotaxis shares jump after FDA clears catheter guidance system 8:13 a.m. Sept. 4, 2014 - Seeking Alpha
10-Q: STEREOTAXIS, INC. 12:29 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Stereotaxis' (STXS) CEO William Mills on Q2 2014 Results - Earnings Call Transcript 8:19 p.m. Aug. 4, 2014 - Seeking Alpha
Q1 2014 Stereotaxis Inc Earnings Conference Call (Webcast) 3:25 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: STEREOTAXIS, INC. 1:08 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Stereotaxis' (STXS) CEO William Mills on Q1 2014 Results - Earnings Call Transcript 8:29 p.m. May 6, 2014 - Seeking Alpha
10-K: STEREOTAXIS, INC. 12:08 p.m. March 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
Stereotaxis - Japan Market Entry And Domestic Vdrive Sales Underway. Maintain Positive Thesis. 12:32 p.m. March 14, 2014 - Seeking Alpha
Stereotaxis' CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:59 p.m. Feb. 25, 2014 - Seeking Alpha
Stereotaxis - Interview Of Experienced Doctor With Stereotaxis' Robotic System 4:04 p.m. Jan. 28, 2014 - Seeking Alpha
Stereotaxis Should Soon Attract Investors Or A Buyer 6:22 p.m. Jan. 19, 2014 - Seeking Alpha
Stereotaxis shares surge following trial completion 7:59 a.m. Jan. 7, 2014 - Seeking Alpha
Stereotaxis - Trading At A Discount To Robotic Peers. Look For This Discount To Close As Sales Growth Resumes 10:55 a.m. Dec. 13, 2013 - Seeking Alpha
10-Q: STEREOTAXIS, INC. 3:08 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Perlmutter Exits Intel After Losing Out to Krzanich and 2 More Heavily Traded Stocks to Follow 3:43 p.m. Oct. 23, 2013 - Wall St. Cheat Sheet

Stereotaxis Receives FDA Clearance of Vdrive(R) With V-CAS(TM) System Along With Regulatory Approval of Odyssey(R) System in Japan 6:31 a.m. Today - GlobeNewswire
Stereotaxis Reports 2014 Third Quarter Financial Results 4:06 p.m. Nov. 5, 2014 - GlobeNewswire
Stereotaxis to Report Third Quarter 2014 Financial Results on November 5, 2014 3:06 p.m. Oct. 30, 2014 - GlobeNewswire
Stereotaxis Secures First Niobe(R) System Order in Japan 5:31 a.m. Sept. 24, 2014 - GlobeNewswire
Stereotaxis Receives FDA Clearance of Vdrive(TM) With V-Loop(TM) System 5:31 a.m. Sept. 4, 2014 - GlobeNewswire
Stereotaxis Reports 2014 Second Quarter Financial Results 3:05 p.m. Aug. 4, 2014 - GlobeNewswire
Stereotaxis to Report Second Quarter 2014 Financial Results on August 4, 2014 5:30 a.m. July 28, 2014 - GlobeNewswire
Stereotaxis to Present Niobe(R) System Technology at Japan Heart Rhythm Society 5:31 a.m. July 21, 2014 - GlobeNewswire
Stereotaxis to Highlight Efficiency, Efficacy and Safety of Its Technology at Cardiostim 2014 5:31 a.m. June 16, 2014 - GlobeNewswire
Stereotaxis Submits 510(k) Application to FDA for Vdrive(TM) With V-CAS(TM) Catheter Advancement System 5:31 a.m. June 10, 2014 - GlobeNewswire
Stereotaxis to Present New Clinical Evidence, Features of Automated Technologies at Heart Rhythm 2014 3:08 p.m. May 6, 2014 - GlobeNewswire
Stereotaxis Reports 2014 First Quarter Financial Results 3:08 p.m. May 6, 2014 - GlobeNewswire
Stereotaxis to Report First Quarter 2014 Financial Results on May 6, 2014 5:31 a.m. April 30, 2014 - GlobeNewswire
Stereotaxis Submits 510(k) Application to FDA for Vdrive(TM) with V-Loop(TM) System 5:31 a.m. April 1, 2014 - GlobeNewswire
Stereotaxis Expands Credit Facility With Silicon Valley Bank to $10 Million 5:30 a.m. March 31, 2014 - GlobeNewswire
Stereotaxis Signs Distribution Agreement for Niobe(R) Technology in Japan 4:06 p.m. Feb. 25, 2014 - GlobeNewswire
Stereotaxis Reports 2013 Fourth Quarter and Full Year Financial Results 4:06 p.m. Feb. 25, 2014 - GlobeNewswire
Stereotaxis to Report Fourth Quarter and Full Year 2013 Financial Results on February 25, 2014 6:30 a.m. Feb. 19, 2014 - GlobeNewswire
Stereotaxis Appoints William C. Mills III to Chief Executive Officer 6:30 a.m. Feb. 14, 2014 - GlobeNewswire
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...